Keller C - Search Results

1

Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.

Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I. Svensson B, et al. Among authors: keller c. Arthritis Rheum. 2005 Nov;52(11):3360-70. doi: 10.1002/art.21298. Arthritis Rheum. 2005. PMID: 16255010 Clinical Trial.

2

Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women.

Forslind K, Keller C, Svensson B, Hafström I; BARFOT Study Group. Forslind K, et al. Among authors: keller c. J Rheumatol. 2003 Dec;30(12):2590-6. J Rheumatol. 2003. PMID: 14719199

3

Bone mineral density in women and men with early rheumatoid arthritis.

Keller C, Hafström I, Svensson B; BARFOT study group. Keller C, et al. Scand J Rheumatol. 2001;30(4):213-20. doi: 10.1080/030097401316909558. Scand J Rheumatol. 2001. PMID: 11578016

4

Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics.

Berglund K, Thysell H, Keller C. Berglund K, et al. Among authors: keller c. J Rheumatol. 1993 Dec;20(12):2051-7. J Rheumatol. 1993. PMID: 8014932

5

Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.

Berglund K, Keller C, Thysell H. Berglund K, et al. Among authors: keller c. Ann Rheum Dis. 1987 Oct;46(10):757-62. doi: 10.1136/ard.46.10.757. Ann Rheum Dis. 1987. PMID: 3500678 Free PMC article.

6

Physical Evidence of Oil Uptake and Toxicity Assessment of Amphiphilic Grafted Nanoparticles Used as Oil Dispersants.

Keller CB, Kurita-Oyamada H, Grayson SM, Denslow ND. Keller CB, et al. Environ Sci Technol. 2022 May 17. doi: 10.1021/acs.est.1c08564. Online ahead of print. Environ Sci Technol. 2022. PMID: 35580268

7

Correction to: Machine learning for rhabdomyosarcoma histopathology.

Frankel AO, Lathara M, Shaw CY, Wogmon O, Jackson JM, Clark MM, Eshraghi N, Keenen SE, Woods AD, Purohit R, Ishi Y, Moran N, Eguchi M, Ahmed FUA, Khan S, Ioannou M, Perivoliotis K, Li P, Zhou H, Alkhaledi A, Davis EJ, Galipeau D, Randall RL, Wozniak A, Schoffski P, Lee CJ, Huang PH, Jones RL, Rubin BP, Darrow M, Srinivasa G, Rudzinski ER, Chen S, Berlow NE, Keller C. Frankel AO, et al. Among authors: keller c. Mod Pathol. 2022 May 16. doi: 10.1038/s41379-022-01098-4. Online ahead of print. Mod Pathol. 2022. PMID: 35578013 No abstract available.

8

Plexin-B2 and Semaphorins Do Not Drive Rhabdomyosarcoma Proliferation or Migration.

Karki A, Purohit R, Nosack S, Bharathy N, Michalek JE, Chen S, Keller C. Karki A, et al. Among authors: keller c. Sarcoma. 2022 May 6;2022:9646909. doi: 10.1155/2022/9646909. eCollection 2022. Sarcoma. 2022. PMID: 35570846 Free PMC article.

9

Behavioral Studies of p62 KO Animals with Implications of a Modulated Function of the Endocannabinoid System.

Keller C, Rading S, Bindila L, Karsak M. Keller C, et al. Cells. 2022 Apr 30;11(9):1517. doi: 10.3390/cells11091517. Cells. 2022. PMID: 35563822 Free PMC article.

10

Systematic Integration of Epigenomic Landscapes in Human and Mouse Blood Cells to Predict Activity and Targets of Regulatory Elements.

Hardison RC, Xiang G, Jansen C, Keller CA, Giardine BM, Cockburn A, He X, Sauria ME, Weaver K, Li Q, Zhang Y. Hardison RC, et al. Among authors: keller ca. FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R5637. FASEB J. 2022. PMID: 35552648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results